These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2148246)

  • 1. [Triapten ointment in the treatment of herpes genitalis in the female].
    Spitzbart H; Seyffert C; Thust U
    Zentralbl Gynakol; 1990; 112(17):1117-20. PubMed ID: 2148246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
    Bratzke B; Orfanos CE; Stavermann T; Ehlers G
    Hautarzt; 1991 Feb; 42(2):96-100. PubMed ID: 1828066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the vaginal cytology of the guinea pig induced by herpes simplex virus.
    Lucia HL; Mayo DR; Hsiung GD
    Acta Cytol; 1983; 27(3):365-70. PubMed ID: 6223477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of fluor].
    Petersen EE
    Gynakologe; 1988 Mar; 21(1):21-5. PubMed ID: 3371754
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical treatment of recurrent genital herpes infections with foscarnet.
    Wallin J; Lernestedt JO; Ogenstad S; Lycke E
    Scand J Infect Dis; 1985; 17(2):165-72. PubMed ID: 3161176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy.
    Rachlis AR
    Clin Dermatol; 1989; 7(3):69-79. PubMed ID: 2478279
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial.
    Sacks SL; Portnoy J; Lawee D; Schlech W; Aoki FY; Tyrrell DL; Poisson M; Bright C; Kaluski J
    J Infect Dis; 1987 Feb; 155(2):178-86. PubMed ID: 2949023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with Hevizos ointment].
    Makleit L
    Acta Pharm Hung; 1993 Jul; 63(4):181-7. PubMed ID: 8379333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study.
    Barton SE; Munday PE; Kinghorn GR; van der Meijden WI; Stolz E; Notowicz A; Rashid S; Schuller JL; Essex-Cater AJ; Kuijpers MH
    Genitourin Med; 1986 Aug; 62(4):247-50. PubMed ID: 2942457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
    Alvarez-McLeod A; Havlik J; Drew KE
    Clin Infect Dis; 1999 Oct; 29(4):937-8. PubMed ID: 10589917
    [No Abstract]   [Full Text] [Related]  

  • 11. Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes.
    Lim KB; Doraisingham S; Thirumoorthy T; Lee CT; Ling AE; Tan T
    Ann Acad Med Singap; 1986 Oct; 15(4):617-22. PubMed ID: 2952046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Herpes genitalis in women].
    Mikrut W
    Wiad Lek; 1985 Sep; 38(18):1305-6. PubMed ID: 4090506
    [No Abstract]   [Full Text] [Related]  

  • 13. [Herpes simplex].
    Fanta D
    Wien Klin Wochenschr; 1981 Dec; 93(24):739-44. PubMed ID: 6281991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of women with cervicitis.
    Marrazzo JM; Martin DH
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S102-10. PubMed ID: 17342663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herpes simplex virus type 2 infection. Etiology, clinical aspects, diagnosis, therapy, HSV-2 and cervix cancer].
    Kunkel M; Oberender H
    Zentralbl Gynakol; 1985; 107(24):1473-8. PubMed ID: 3004067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virostatic treatment of herpes simplex infections of variable severity].
    Raab R; Söltz-Szöts J
    Hautarzt; 1990 Aug; 41(8):413-5. PubMed ID: 2272824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing of the in vivo therapeutic efficacy on the cutaneous herpes simplex infections of the autochthonous product 5% Acyclovir ointment.
    Crişan I; Rojanschi D; Petica M; Fodor C; Morar S; Muţiu A
    Rom J Virol; 1996; 47(1-4):13-24. PubMed ID: 9495780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.